Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium

被引：30

作者：

Till, M

Wixson, RL

Pertel, PE

机构：

[1] Northwestern Univ, Sch Med, Dept Med, Div Infect Dis, Chicago, IL 60611 USA

[2] Northwestern Univ, Sch Med, Dept Orthopaed Surg, Chicago, IL 60611 USA

[3] Northwestern Univ, Sch Med, Dept Immunol Microbiol, Chicago, IL 60611 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2002年 / 34卷 / 10期

关键词：

D O I：

10.1086/340265

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The incidence of nosocomial infections caused by vancomycin-resistant enterococci has risen substantially during the past 15 years. We report the use of linezolid for the successful treatment of hip prosthesis infection associated with osteomyelitis due to vancomycin-resistant Enterococcus faecium.

引用

页码：1412 / 1414

页数：3

共 12 条

[1]

[Anonymous], 2000, MED LETT DRUGS THER, V42, P45

[2] ENTEROCOCCAL OSTEOMYELITIS IN THE DIABETIC PATIENT [J].